AMH and breast carcinoma: Several studies have demonstrated that asymptomatic BRCA mutation carriers [28–30] as well as breast cancer patients with BRCA mutation [31] have a significantly decreased serum anti-Müllerian hormone (AMH) level, a biomarker representing a woman’s reproductive competence [32].